Intravenous iron and recombinant human erythropoietin in cancer patients [5]

Journal of Clinical Oncology

Volumn 23, Issue 3, 2005, Pages 651-652

  Beguin, Yves ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC HYDROXIDE SUCROSE; FERRITIN; FERROUS GLUCONATE; HEMOGLOBIN; IRON; IRON DEXTRAN; IRON SACCHARATE; RECOMBINANT ERYTHROPOIETIN; ANTINEOPLASTIC AGENT;

ANEMIA; CANCER; DOSE RESPONSE; FERRITIN BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY; LETTER; NAUSEA; PRIORITY JOURNAL; QUALITY OF LIFE; CHEMICALLY INDUCED DISORDER; DRUG INTERACTION; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; NEOPLASM; NOTE; REPRODUCIBILITY;

ANEMIA; ANTINEOPLASTIC AGENTS; DRUG INTERACTIONS; ERYTHROPOIETIN, RECOMBINANT; HUMANS; INFUSIONS, INTRAVENOUS; IRON; NEOPLASMS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN;

EID: 14544282901     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.184     Document Type: Letter

References (10)

1. Auerbach M, Ballard H, Trout JR, et al: Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: A multicenter, open-label, randomized trial. J Clin Oncol 22:1301-1307, 2004
2. Weiss G: Pathogenesis and treatment of anaemia of chronic disease. Blood Rev 16:87-96, 2002
3. Brugnara C, Chambers LA, Malynn E, et al: Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: Iron-deficient erythropoiesis in iron-replete subjects. Blood 81:956-964, 1993
4. d'Onofrio G, Chirillo R, Zini G, et al: Simultaneous measurement of reticulocyte and red blood cell indices in healthy subjects and patients with microcytic and macrocytic anemia. Blood 85:818-823, 1995
5. Macdougall IC, Tucker B, Thompson J, et al: A randomized controlled study of iron supplementation in patients treated with erythropoietin. Kidney Int 50:1694-1699, 1996
6. Besarab A, Amin N, Ahsan M, et al: Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients. J Am Soc Nephrol 11:530-538, 2000
7. Haurani FI, Green D, Young K: Iron absorption in hypoferremia. Am J Med Sci 249:537-547, 1965
8. Weinberg ED: The role of iron in cancer. Eur J Cancer Prev 5:19-36, 1996
9. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis 30:S192-S240, 1997 (4 suppl 3)
10. Drueke TB, Barany P, Cazzola M, et al: Management of iron deficiency in renal anemia: Guidelines for the optimal therapeutic approach in erythropoietin-treated patients. Clin Nephrol 48:1-8, 1997